Kamal Haddouali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kamal Haddouali has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Hicham El Otmani
Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco
23 shared publications - Salma Bellakhdar
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
22 shared publications Bouchra El Moutawakil
Hassan II University of Casablanca, Department of Neurology and Clinical Neurophysiology, IBN ROCHD University Hospital of Casablanca 20100, Casablanca Morocco. Faculty of Medicine and Pharmacy of Casablanca, Laboratory of Genetics 20000 Casablanca, Morocco
19 shared publicationsMohammed Abdoh Rafai
Department of Neurology and Neurophysiological Explorations, Ibn Rochd University Hospital - Hassan II University, Faculty of Medicine and Pharmacy, Casablanca, MAR
16 shared publicationsM.A. Rafai
Département de neurologie, faculté de médecine et de pharmacie, université Hassan II, hôpital Ibn-Rochd, rue Tarik-Ibn-Ziad, 20000 Casablanca, Maroc
7 shared publicationsHicham El Otmani
Department of Neurology and Neurophysiological Explorations, Ibn Rochd University Hospital - Hassan II University, Faculty of Medicine and Pharmacy, Casablanca, MAR
5 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- Open Access
- 26 March 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Multifocal motor neuropathy secondary to gluten intolerance: a case report
Background: Peripheral nervous system manifestations of gluten sensitivity usually present as distal symmetric axonal polyneuropathy, small fiber neuropathy, or sensory neuropathy, often accompanied by ataxia or painful symptoms. By contrast, motor neuropathies are extremely rare, with only a few cases of multifocal motor neuropathy reported. Notably, the most recent guidelines of the European Society for the Study of Coeliac Disease do not recognize multifocal motor neuropathy as a classical neurological manifestation of gluten-related disorders. The main differential diagnoses include amyotrophic lateral sclerosis and chronic inflammatory demyelinating polyneuropathy. Currently, strict adherence to a gluten-free diet remains the only therapeutic option. Although clinical improvement is not universal, when observed, it strongly supports the causal role of gluten-related neurotoxicity. Case presentation: We report the case of a 50-year-old North African man with a history of dermatitis herpetiformis and persistent chronic diarrhea. Over the past 5 years, he developed progressive asymmetric motor weakness. Clinical examination revealed an asymmetric, pure motor, peripheral neurogenic syndrome, confirmed by nerve conduction studies, without evidence of proximal conduction block. Cerebrospinal fluid analysis showed elevated protein levels (0.75 g/L), and serum anti-GD3 IgM antibodies were positive. Brachial plexus magnetic resonance imaging revealed bilateral hypertrophy on T1-weighted sequences, with hyperintensity on short tau inversion recovery sequences but no contrast enhancement. The motor deficit gradually improved after the introduction of a gluten-free diet. The patient also received intravenous immunoglobulin without significant clinical benefit. On the basis of clinical, paraclinical, and follow-up findings, a diagnosis of multifocal motor neuropathy secondary to gluten intolerance was established. Conclusion: This case highlights the importance of considering gluten intolerance as a potential etiology, particularly given the reversible nature of this neuropathy, which can otherwise be misdiagnosed as a more severe condition such as amyotrophic lateral sclerosis. Further studies are needed to better elucidate the pathophysiology of this rare gluten-related neurological phenotype.
- 26 March 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessMultifocal motor neuropathy secondary to gluten intolerance: a case report
Background: Peripheral nervous system manifestations of gluten sensitivity usually present as distal symmetric axonal polyneuropathy, small fiber neuropathy, or sensory neuropathy, often accompanied by ataxia or painful symptoms. By contrast, motor neuropathies are extremely rare, with only a few cases of multifocal motor neuropathy reported. Notably, the most recent guidelines of the European Society for the Study of Coeliac Disease do not recognize multifocal motor neuropathy as a classical neurological manifestation of gluten-related disorders. The main differential diagnoses include amyotrophic lateral sclerosis and chronic inflammatory demyelinating polyneuropathy. Currently, strict adherence to a gluten-free diet remains the only therapeutic option. Although clinical improvement is not universal, when observed, it strongly supports the causal role of gluten-related neurotoxicity. Case presentation: We report the case of a 50-year-old North African man with a history of dermatitis herpetiformis and persistent chronic diarrhea. Over the past 5 years, he developed progressive asymmetric motor weakness. Clinical examination revealed an asymmetric, pure motor, peripheral neurogenic syndrome, confirmed by nerve conduction studies, without evidence of proximal conduction block. Cerebrospinal fluid analysis showed elevated protein levels (0.75 g/L), and serum anti-GD3 IgM antibodies were positive. Brachial plexus magnetic resonance imaging revealed bilateral hypertrophy on T1-weighted sequences, with hyperintensity on short tau inversion recovery sequences but no contrast enhancement. The motor deficit gradually improved after the introduction of a gluten-free diet. The patient also received intravenous immunoglobulin without significant clinical benefit. On the basis of clinical, paraclinical, and follow-up findings, a diagnosis of multifocal motor neuropathy secondary to gluten intolerance was established. Conclusion: This case highlights the importance of considering gluten intolerance as a potential etiology, particularly given the reversible nature of this neuropathy, which can otherwise be misdiagnosed as a more severe condition such as amyotrophic lateral sclerosis. Further studies are needed to better elucidate the pathophysiology of this rare gluten-related neurological phenotype.
- Open Access
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Paroxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Open AccessParoxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Paraneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Open AccessParaneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.
- Open Access
- 5 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80079
Acute Pure Motor Cranial Polyneuropathy: A Rare Form of Guillain-Barré Syndrome
Guillain-Barré syndrome (GBS) typically presents with ascending flaccid paralysis, but variants with exclusive cranial nerve involvement are rare. We report an atypical case of GBS with isolated motor cranial nerve involvement. A 19-year-old female with no significant medical history presented with bilateral ptosis and diplopia, which progressed over 10 days to bilateral facial paresis, lingual and masseter weakness, and severe dysphagia. Neurological examination revealed symmetric involvement of cranial nerves III, IV, VI, VII, IX, and XII, without sensory or tendon reflex abnormalities. Nerve conduction studies showed absent motor responses in the facial nerve and blink reflex, along with repetitive distal compound muscle action potentials, initially suggestive of congenital myasthenia. These findings normalized after the discontinuation of acetylcholinesterase inhibitors. Assessment of the neuromuscular junction was normal. Electromyography revealed neurogenic changes in the masseters and genioglossus. Brain MRI and cerebrospinal fluid analysis were normal, and infectious serologies and autoimmune screening were negative. The patient was diagnosed with the oculo-pharyngeal variant of GBS. Despite treatment with intravenous immunoglobulin and five sessions of plasmapheresis, no significant improvement was observed in the short term. At six months, the patient continued to experience persistent ophthalmoparesis, dysphagia, and facial amyotrophy, requiring gastrostomy placement. This case highlights the rare oculo-pharyngeal variant of GBS, characterized by exclusive cranial nerve involvement, which poses diagnostic challenges and often leads to poor functional outcomes. Early recognition and prompt treatment are crucial to improving prognosis.
- 5 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80079
Open AccessAcute Pure Motor Cranial Polyneuropathy: A Rare Form of Guillain-Barré Syndrome
Guillain-Barré syndrome (GBS) typically presents with ascending flaccid paralysis, but variants with exclusive cranial nerve involvement are rare. We report an atypical case of GBS with isolated motor cranial nerve involvement. A 19-year-old female with no significant medical history presented with bilateral ptosis and diplopia, which progressed over 10 days to bilateral facial paresis, lingual and masseter weakness, and severe dysphagia. Neurological examination revealed symmetric involvement of cranial nerves III, IV, VI, VII, IX, and XII, without sensory or tendon reflex abnormalities. Nerve conduction studies showed absent motor responses in the facial nerve and blink reflex, along with repetitive distal compound muscle action potentials, initially suggestive of congenital myasthenia. These findings normalized after the discontinuation of acetylcholinesterase inhibitors. Assessment of the neuromuscular junction was normal. Electromyography revealed neurogenic changes in the masseters and genioglossus. Brain MRI and cerebrospinal fluid analysis were normal, and infectious serologies and autoimmune screening were negative. The patient was diagnosed with the oculo-pharyngeal variant of GBS. Despite treatment with intravenous immunoglobulin and five sessions of plasmapheresis, no significant improvement was observed in the short term. At six months, the patient continued to experience persistent ophthalmoparesis, dysphagia, and facial amyotrophy, requiring gastrostomy placement. This case highlights the rare oculo-pharyngeal variant of GBS, characterized by exclusive cranial nerve involvement, which poses diagnostic challenges and often leads to poor functional outcomes. Early recognition and prompt treatment are crucial to improving prognosis.
- Open Access
- 24 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e79539
Atypical Electrophysiological Pattern in Hypokalemic Periodic Paralysis With CACNA1S Mutation: A Case Report
Hypokalemic periodic paralysis type 1 (PPHy-1) is a rare autosomal dominant disorder caused by mutations in the CACNA1S gene, leading to recurrent muscle weakness associated with hypokalemia. We describe a 19-year-old male presenting with recurrent episodes of muscle weakness lasting from 2 to 48 hours. During an attack, clinical examination revealed tetraparesis with axial motor deficits, but no bulbar or facial involvement. Serum potassium levels were 2.5 mmol/L, and nerve conduction studies (NCS) showed asymmetrical decrement in motor amplitudes. A long exercise test (LET) post-attack revealed pattern IV, an atypical finding for PPHy-1. Whole exome sequencing confirmed a heterozygous mutation in the CACNA1S gene, establishing the diagnosis. The patient responded well to oral potassium supplementation and prophylactic acetazolamide, which reduced the frequency of attacks. This case highlights the importance of integrating clinical, electrophysiological, and genetic findings in diagnosing PPHy-1. The unusual LET pattern IV suggests variability in the expression of PPHy-1, warranting further investigation into the variability of LET patterns in this disorder.
- 24 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e79539
Open AccessAtypical Electrophysiological Pattern in Hypokalemic Periodic Paralysis With CACNA1S Mutation: A Case Report
Hypokalemic periodic paralysis type 1 (PPHy-1) is a rare autosomal dominant disorder caused by mutations in the CACNA1S gene, leading to recurrent muscle weakness associated with hypokalemia. We describe a 19-year-old male presenting with recurrent episodes of muscle weakness lasting from 2 to 48 hours. During an attack, clinical examination revealed tetraparesis with axial motor deficits, but no bulbar or facial involvement. Serum potassium levels were 2.5 mmol/L, and nerve conduction studies (NCS) showed asymmetrical decrement in motor amplitudes. A long exercise test (LET) post-attack revealed pattern IV, an atypical finding for PPHy-1. Whole exome sequencing confirmed a heterozygous mutation in the CACNA1S gene, establishing the diagnosis. The patient responded well to oral potassium supplementation and prophylactic acetazolamide, which reduced the frequency of attacks. This case highlights the importance of integrating clinical, electrophysiological, and genetic findings in diagnosing PPHy-1. The unusual LET pattern IV suggests variability in the expression of PPHy-1, warranting further investigation into the variability of LET patterns in this disorder.
- Open Access
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 419-421
Pseudovascular Revelation of Seropositive Neuromyelitis Optica Spectrum Disorder: A Case Report
Symptom onset in Neuromyelitis Optica spectrum disorder (NMOSD) is often acute, while sudden onset is rare and suggests vascular causes. We report the case of a 63-year-old woman who had two sudden attacks, blindness in the left eye and weakness of the lower limbs. The presence of a diencephalic hypersignal around the third ventricle and a bright spotty lesion on the MRI had evoked the NMOSD diagnosis which was confirmed by positive anti-aquaporin 4 antibodies in the serum. The patient was treated with cyclophosphamide with no relapses after 6 months of treatment. Few case reports have been published on this subject, testifying to the rarity of this "pseudo-vascular" mode of revelation of NMOSD, which may be a source of diagnostic error or delay.
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 419-421
Open AccessPseudovascular Revelation of Seropositive Neuromyelitis Optica Spectrum Disorder: A Case Report
Symptom onset in Neuromyelitis Optica spectrum disorder (NMOSD) is often acute, while sudden onset is rare and suggests vascular causes. We report the case of a 63-year-old woman who had two sudden attacks, blindness in the left eye and weakness of the lower limbs. The presence of a diencephalic hypersignal around the third ventricle and a bright spotty lesion on the MRI had evoked the NMOSD diagnosis which was confirmed by positive anti-aquaporin 4 antibodies in the serum. The patient was treated with cyclophosphamide with no relapses after 6 months of treatment. Few case reports have been published on this subject, testifying to the rarity of this "pseudo-vascular" mode of revelation of NMOSD, which may be a source of diagnostic error or delay.
- Open Access
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 415-418
The Use of Tenecteplase in Combination with Brain Scan Analysis in Thrombolysis of Acute Ischemic Stroke: A Moroccan Experience
Objective: Intravenous thrombolysis of acute ischemic stroke uses alteplase, which has long been approved for this indication. In the same context, studies on Tenecteplase have demonstrated the efficacy and safety of this molecule, which we use in our structure following clinical and radiological evaluation using non-enhanced computed tomography. Our aim is to share our institutional approach. Materials and Methods: Retrospective, descriptive, cross-sectional study in the neurology department of Casablanca over a 5-year period from 01 January 2018 to 31 December 2022. We included all patients with suspected acute stroke who underwent IVT with Tenecteplase with an Alberta Stroke Program Early CT Score greater than or equal to 7 on non-enhanced cerebral computed tomography. The Modified Rankin Scale was evaluated at 3 months. Results: During these 5 years, 140 patients (49% were females) had received Tenecteplase thrombolytic therapy. The mean age was 67 years, mean National Institutes of Health Stroke Scale was 13/42, mean Alberta Stroke Program Early CT Score was 8/10. 97% of the patients received a dose of 0.25mg/kg of Tenecteplase in a mean time of 210min from the onset of symptoms. The Modified Rankin Scale between 0 and 2 at 3 months was in 46% and 13% of death. Conclusion: We are satisfied with the results of Intravenous thrombolysis with Tenecteplase. However, we are convinced of the limited information provided by a non-enhanced cerebral computed tomography to brain magnetic resonance imaging which remains difficult to access in our context.
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 415-418
Open AccessThe Use of Tenecteplase in Combination with Brain Scan Analysis in Thrombolysis of Acute Ischemic Stroke: A Moroccan Experience
Objective: Intravenous thrombolysis of acute ischemic stroke uses alteplase, which has long been approved for this indication. In the same context, studies on Tenecteplase have demonstrated the efficacy and safety of this molecule, which we use in our structure following clinical and radiological evaluation using non-enhanced computed tomography. Our aim is to share our institutional approach. Materials and Methods: Retrospective, descriptive, cross-sectional study in the neurology department of Casablanca over a 5-year period from 01 January 2018 to 31 December 2022. We included all patients with suspected acute stroke who underwent IVT with Tenecteplase with an Alberta Stroke Program Early CT Score greater than or equal to 7 on non-enhanced cerebral computed tomography. The Modified Rankin Scale was evaluated at 3 months. Results: During these 5 years, 140 patients (49% were females) had received Tenecteplase thrombolytic therapy. The mean age was 67 years, mean National Institutes of Health Stroke Scale was 13/42, mean Alberta Stroke Program Early CT Score was 8/10. 97% of the patients received a dose of 0.25mg/kg of Tenecteplase in a mean time of 210min from the onset of symptoms. The Modified Rankin Scale between 0 and 2 at 3 months was in 46% and 13% of death. Conclusion: We are satisfied with the results of Intravenous thrombolysis with Tenecteplase. However, we are convinced of the limited information provided by a non-enhanced cerebral computed tomography to brain magnetic resonance imaging which remains difficult to access in our context.
- Open Access
- 31 May 2023
- Published by Université Paris Cité in Emerging Neurologist
- Vol. 2 (1) , 10-12
Reversible splenial lesion of the corpus callosum secondary to severe intracranial hypertension in children: a case report
Introduction. Reversible lesions in the splenium of the corpus callosum are a recognized radio-clinical entity, which is rarely associated with idiopathic intracranial hypertension, especially in children. We present a case. Case report. We describe the case of an 11-year-old prepubescent female patient with no significant medical history. She presented with idiopathic intracranial hypertension syndrome and exhibited a nodular lesion in the splenium of the corpus callosum on the MRI scan. Initial medical treatment with acetazolamide and a subtractive lumbar puncture failed to improve the patient's condition. Consequently, an emergency ventriculoperitoneal shunt procedure was performed, resulting in a favorable clinical outcome. A follow-up MRI was conducted six months later, revealing normalization of the imaging results. Conclusion. Further studies are needed to understand the pathophysiology of reversible lesions in the splenium of the corpus callosum during idiopathic intracranial hypertension.
- 31 May 2023
- Published by Université Paris Cité in Emerging Neurologist
- Vol. 2 (1) , 10-12
Open AccessReversible splenial lesion of the corpus callosum secondary to severe intracranial hypertension in children: a case report
Introduction. Reversible lesions in the splenium of the corpus callosum are a recognized radio-clinical entity, which is rarely associated with idiopathic intracranial hypertension, especially in children. We present a case. Case report. We describe the case of an 11-year-old prepubescent female patient with no significant medical history. She presented with idiopathic intracranial hypertension syndrome and exhibited a nodular lesion in the splenium of the corpus callosum on the MRI scan. Initial medical treatment with acetazolamide and a subtractive lumbar puncture failed to improve the patient's condition. Consequently, an emergency ventriculoperitoneal shunt procedure was performed, resulting in a favorable clinical outcome. A follow-up MRI was conducted six months later, revealing normalization of the imaging results. Conclusion. Further studies are needed to understand the pathophysiology of reversible lesions in the splenium of the corpus callosum during idiopathic intracranial hypertension.
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S176
Mode d’entrée sensitif au cours de la sclérose en plaques : source de retard diagnostique
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S176
Mode d’entrée sensitif au cours de la sclérose en plaques : source de retard diagnostique